SU1316556A3 - Способ получени производных пролина или их фармацевтически приемлемых солей - Google Patents

Способ получени производных пролина или их фармацевтически приемлемых солей Download PDF

Info

Publication number
SU1316556A3
SU1316556A3 SU823450352A SU3450352A SU1316556A3 SU 1316556 A3 SU1316556 A3 SU 1316556A3 SU 823450352 A SU823450352 A SU 823450352A SU 3450352 A SU3450352 A SU 3450352A SU 1316556 A3 SU1316556 A3 SU 1316556A3
Authority
SU
USSR - Soviet Union
Prior art keywords
proline
meoh
water
methylpropanoyl
acid
Prior art date
Application number
SU823450352A
Other languages
English (en)
Russian (ru)
Inventor
Танака Садао
Куромару Киенори
Фудзимура Ясуо
Мацунага Исао
Иваока Томояси
Обатаке Норико
Аоно Дзунитиро
Хинохара Есиказу
Накано Хидеки
Фукусима Масафуми
Набата Хироюки
Сакаи Казусиге
Хата Сун-Ити
Original Assignee
Чугаи Сейяку Кабусики Кайся (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP56094002A external-priority patent/JPS57209270A/ja
Priority claimed from JP56137823A external-priority patent/JPS5839661A/ja
Application filed by Чугаи Сейяку Кабусики Кайся (Фирма) filed Critical Чугаи Сейяку Кабусики Кайся (Фирма)
Application granted granted Critical
Publication of SU1316556A3 publication Critical patent/SU1316556A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SU823450352A 1981-06-19 1982-06-16 Способ получени производных пролина или их фармацевтически приемлемых солей SU1316556A3 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56094002A JPS57209270A (en) 1981-06-19 1981-06-19 Proline derivative
JP56137823A JPS5839661A (ja) 1981-09-03 1981-09-03 プロリン誘導体の製法

Publications (1)

Publication Number Publication Date
SU1316556A3 true SU1316556A3 (ru) 1987-06-07

Family

ID=26435270

Family Applications (1)

Application Number Title Priority Date Filing Date
SU823450352A SU1316556A3 (ru) 1981-06-19 1982-06-16 Способ получени производных пролина или их фармацевтически приемлемых солей

Country Status (19)

Country Link
KR (1) KR890000769B1 (xx)
AT (1) AT377496B (xx)
CA (1) CA1235120A (xx)
CH (1) CH651825A5 (xx)
DE (1) DE3222779A1 (xx)
DK (1) DK156054C (xx)
ES (2) ES513277A0 (xx)
FI (1) FI75804C (xx)
FR (1) FR2508040B1 (xx)
GB (1) GB2102412B (xx)
HU (1) HU188177B (xx)
IL (1) IL65954A (xx)
IT (1) IT1157053B (xx)
MX (2) MX171888B (xx)
NL (1) NL193282C (xx)
NO (1) NO156408C (xx)
PT (1) PT75076B (xx)
SE (1) SE453595B (xx)
SU (1) SU1316556A3 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
US4783334A (en) * 1986-01-21 1988-11-08 Chugai Seiyaku Kabushiki Kaisha Stable solid preparation of thiol ester derivative
ZA896851B (en) 1988-09-14 1990-06-27 Hoffmann La Roche Use of ace-inhibitors
DK0634175T3 (da) * 1993-07-15 2001-04-30 Hoffmann La Roche Farmaceutisk kombination, der indeholder en hæmmer af renin-angiotensin-systemet og en endothelin-antagonist

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA802420B (en) * 1979-05-18 1981-04-29 Squibb & Sons Inc Aminoacyl derivatives of mercaptoacyl amino acids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1. Патент GB 2050359, кл. С 07 D 207/16, 1981. 2. Европейский патент № 0009898, кл. С 07 С 103/52, 1980. *

Also Published As

Publication number Publication date
KR840000488A (ko) 1984-02-22
NO156408B (no) 1987-06-09
DK273082A (da) 1982-12-20
GB2102412B (en) 1985-01-09
CH651825A5 (de) 1985-10-15
IL65954A (en) 1986-03-31
ES520582A0 (es) 1984-04-01
IT1157053B (it) 1987-02-11
ATA558581A (de) 1984-08-15
DK156054C (da) 1989-11-06
PT75076A (en) 1982-07-01
DE3222779A1 (de) 1983-01-27
FI75804B (fi) 1988-04-29
SE453595B (sv) 1988-02-15
SE8203814L (sv) 1982-12-20
HU188177B (en) 1986-03-28
KR890000769B1 (ko) 1989-04-05
NO821997L (no) 1982-12-20
IL65954A0 (en) 1982-09-30
MX171888B (es) 1993-11-23
DK156054B (da) 1989-06-19
CA1235120A (en) 1988-04-12
PT75076B (en) 1984-05-09
FI822171A0 (fi) 1982-06-16
ES8307216A1 (es) 1983-07-01
FI822171L (fi) 1982-12-20
NL193282C (nl) 1999-05-06
FR2508040B1 (fr) 1986-07-04
AT377496B (de) 1985-03-25
ES513277A0 (es) 1983-07-01
DE3222779C2 (xx) 1991-01-03
FR2508040A1 (fr) 1982-12-24
NL193282B (nl) 1999-01-04
NL8202472A (nl) 1983-01-17
NO156408C (no) 1987-09-16
FI75804C (fi) 1988-08-08
MX155724A (es) 1988-04-20
GB2102412A (en) 1983-02-02
ES8403868A1 (es) 1984-04-01
IT8267772A0 (it) 1982-06-16

Similar Documents

Publication Publication Date Title
US5514559A (en) Immunologically active conjugates and method for their preparation
SU1739852A3 (ru) Способ получени пептидов или их фармацевтически приемлемых солей
JPS6059226B2 (ja) プロリン誘導体および関連化合物
HU201329B (en) Process for production of substituated on nitrogen atom of methil-amin group of staurosporen derivatives and medical compositions containing them
JP2008508348A (ja) 銅含有アミンオキシダーゼを阻害するための化合物およびその使用
HUT52525A (en) Process for producing retroviral proteaz-inhibitors and pharmaceutical compositions containing them as active components
SU1316556A3 (ru) Способ получени производных пролина или их фармацевтически приемлемых солей
US4322436A (en) Novel substituted phenylacetic acid amide compounds
US4420490A (en) Substituted phenylacetic acid amide compounds
US4250192A (en) Novel substituted phenylacetic acid amide compounds
SU1272982A3 (ru) Способ получени производных пролина или их фармацевтически приемлемых солей
JPH11510684A (ja) トリペプチジルペプチダーゼインヒビター
FI62066C (fi) Foerfarande foer framstaellning av antitrombotiska cyklohexylfenylderivat
EP0556152B1 (en) Pyridinium derivatives and their use in determining connective tissue disorders in humans and animals
JP2659990B2 (ja) 結晶性キナプリルおよびその製法
US4678800A (en) Gamma-r-glutamoyl derivatives
FI83656B (fi) Nya tyroninderivat.
CZ290747B6 (cs) Deriváty L-argininu s inhibičním účinkem na NO syntázu, způsob jejich přípravy, farmaceutický prostředek, který je obsahuje a jejich pouľití
JPH0776211B2 (ja) ピログルタミン酸誘導体
JP3997141B2 (ja) チロペプチンａ類縁体
EP1140980B1 (fr) Composes pseudopeptidiques dotes d'une activite inhibitrice a l'egard des voies activees par les proteines a activite tyrosine kinase et les compositions pharmaceutiques les contenant
SU702030A1 (ru) -Пептидилтиогликозиды ацетил- -глюкозамина в качестве лигандов в аффинной хроматографии
HAYASHI et al. Studies on angiotensin-converting enzyme inhibitors. I. Syntheses and angiotensin-converting enzyme inhibitory activity of 2-(3-mercaptopropionyl)-1, 2, 3, 4-tetrahydroisoquinoline-3-carboxylic acid derivatives
JPH0147463B2 (xx)
JPH06145143A (ja) 新規なトリプトファン誘導体